Status:
COMPLETED
A User Study With Vernivia® for Bacterial Vaginosis.
Lead Sponsor:
PepTonic Medical AB
Collaborating Sponsors:
Key2Compliance
Replior AB
Conditions:
Bacterial Vaginoses
Eligibility:
FEMALE
16-49 years
Phase:
NA
Brief Summary
This is an open user study to evaluate D005 vagnial mousse with regards to user-friendliness, and measure time from start of treatment to symptom relief and measure the clarity of instructional materi...
Eligibility Criteria
Inclusion
- Age 16 - 49 years Informed consent to take part in the study Bacterial vaginosis (based on self-assessment or diagnosed by a doctor or midwife) Access to a smartphone
Exclusion
- Symptoms of vaginal candida infection and/or Pregnancy
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 22 2021
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT06104098
Start Date
April 1 2021
End Date
July 22 2021
Last Update
October 31 2023
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Mama Mia Väla
Väla, Helsingborg, Sweden, 25467
2
Mednika AB
Linköping, Sweden, 58758
3
Hälsomedicinskt Center
Lomma, Sweden, 23439
4
Mama Mia Barnmorskemottagning
Malmo, Sweden, 21141